Cargando…
Trimerization and Genotype–Phenotype Correlation of COL4A5 Mutants in Alport Syndrome
INTRODUCTION: Alport syndrome is a hereditary glomerulonephritis that results from the disruption of collagen α345(IV) heterotrimerization caused by mutation in COL4A3, COL4A4 or COL4A5 genes. Many clinical studies have elucidated the correlation between genotype and phenotype, but there is still mu...
Autores principales: | Kamura, Misato, Yamamura, Tomohiko, Omachi, Kohei, Suico, Mary Ann, Nozu, Kandai, Kaseda, Shota, Kuwazuru, Jun, Shuto, Tsuyoshi, Iijima, Kazumoto, Kai, Hirofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210609/ https://www.ncbi.nlm.nih.gov/pubmed/32405592 http://dx.doi.org/10.1016/j.ekir.2020.01.008 |
Ejemplares similares
-
Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome
por: Yokota, Tsubasa, et al.
Publicado: (2017) -
The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model
por: Sannomiya, Yuya, et al.
Publicado: (2021) -
Metformin ameliorates the severity of experimental Alport syndrome
por: Omachi, Kohei, et al.
Publicado: (2021) -
CyclosporinA Derivative as Therapeutic Candidate for Alport Syndrome by Inducing Mutant Type IV Collagen Secretion
por: Kuwazuru, Jun, et al.
Publicado: (2023) -
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5
por: Yamamura, Tomohiko, et al.
Publicado: (2020)